湖北久安医药集团(以下简称“久安医药”),总部位于湖北武汉,是一家以药品研发、生产及推广服务为主导的集团企业。2017年,久安医药成功收购武汉久安药业有限公司(成立于1951年,原用名“武汉第二制药厂”,是新中国首批制药企业,现有药品注册批准文号130余项,以下简称“久安药业”),建立了高品质精品药生产基地,完成收购以来,集团投入大量人力物力进行了厂房扩建、设备引进和技术革新,已陆续重新上市了10多个短缺药、急(抢)救药。2018年,久安医药全资成立了武汉久安药物研究院,创立了自己的创新制剂技术平台,以平台&合伙人的模式吸引了众多医药技术专家加盟。
久安医药成立以来,始终秉承创新发展的理念,严格执行国家相关法规,建立了完善的生产质量管理体系。1989年,中国第一个复方氨基酸注射液(18AA-V)诞生于久安,2023年......
Wuhan Jiu'An Pharmaceutical Co., Ltd. was established in October 1999. Its predecessor was Jiu'An pharmaceutical established in 1951. At that time, it was one of the 80 core pharmaceutical enterprises in China. On October 25, 2002, after the approval of Hubei Provincial Drug Administration, our company acquired 60.5 mu of land in the "Wuhan Pharmaceutical Industrial Park" in Miaoshan community, Wuhan East Lake High Tech Development Zone, and rebuilt the production base in the center of the city as a whole.